Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review

Author:

Nabia Sarah1,Wonodi Chizoba Barbara1,Vilajeliu Alba2,Sussman Sabine3,Olson Katharine4,Cooke Rianna4ORCID,Udayakumar Krishna4ORCID,Twose Claire5,Ezeanya Nwamaka6ORCID,Adefarrell Adewumi Adetola6,Lindstrand Ann2

Affiliation:

1. USAID’s MOMENTUM Country and Global Leadership, International Vaccine Access Center (IVAC), Johns Hopkins University, Baltimore, MD 21231, USA

2. Department of Immunization, Vaccines & Biologicals (IVB), World Health Organization, WHO, 1211 Geneva, Switzerland

3. Duke-Robert J. Margolis, MD, Center for Health Policy, Washington, DC 20004, USA

4. Duke Global Health Innovation Center, Durham, NC 27701, USA

5. Welch Medical Library, Johns Hopkins University, Baltimore, MD 21205, USA

6. Direct Consulting and Logistics Limited, Abuja 901101, Federal Capital Territory, Nigeria

Abstract

The COVID-19 vaccination is a crucial public health intervention for controlling the spread and severity of the SARS-CoV2 virus. COVID-19 vaccines have been developed in record time, but their deployment has varied across countries, owing to differences in health system capacity, demand for the vaccine, and purchasing power of countries. The aim of this rapid review is to summarize and synthesize experiences on COVID-19 vaccine service delivery and integration to inform future COVID-19 vaccination programming and contribute to the knowledge base for future pandemic management. A systematic search was conducted in PubMed, Scopus, and Global Index Medicus databases. Twenty-five studies were included in the analysis. Included studies spanned nine countries where COVID-19 vaccines were delivered through mass, mobile, and fixed-post vaccination service delivery models. There was limited evidence of integrating COVID-19 vaccines into routine services for pregnant women, people who inject drugs, and leveraging existing health programs to deliver COVID-19 vaccines to the general population. Common challenges reported were vaccine skepticism, lack of adequate health workers, and linguistic barriers to access. Partnerships with a variety of stakeholders and the involvement of volunteers were vital in overcoming barriers and contributed to the efficient functioning of COVID-19 vaccination programs.

Funder

United States Agency for International Development

Bill & Melinda Gates Foundation

The Rockefeller Foundation

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference48 articles.

1. Coronavirus Pandemic (COVID-19);Mathieu;Our World Data,2020

2. Global Impact of the First Year of COVID-19 Vaccination: A Mathematical Modelling Study;Watson;Lancet Infect. Dis.,2022

3. International Monetary Fund (2023, February 15). IMF-WHO COVID-19 Vaccine Tracker. Available online: https://www.imf.org/en/Topics/imf-and-covid19/IMF-WHO-COVID-19-Vaccine-Tracker.

4. COVID-19 Vaccine Challenges: What Have We Learned so Far and What Remains to Be Done?;Forman;Health Policy,2021

5. Challenges in Ensuring Global Access to COVID-19 Vaccines: Production, Affordability, Allocation, and Deployment;Wouters;Lancet Lond. Engl.,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3